Bayer Down on Verdict to Pay $2.1B to Plaintiff in Roundup Litigation [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
Bayer reported that, on March 21, the jury at the Barnes Roundup trial in the State Court of Cobb County, Georgia, reached a verdict in favor of the plaintiff. Bayer has been ordered by the jury to pay $2.1 billion to the plaintiff ($2 billion in punitive damages and $65 million in compensatory damages). However, the company disagreed with the jury's verdict. In the past year, shares of Bayer have lost 17.7% compared with the industry's decline of 2.8%. Image Source: Zacks Investment Research Glyphosate is the active ingredient in a number of Monsanto's herbicides, including Roundup branded products. Bayer acquired Roundup weedkiller through Monsanto's buyout in 2018. However, several lawsuits have been filed by people for the same, alleging that Monsanto's herbicide caused them to develop non-Hodgkin lymphoma (NHL) or related cancers. It has also been alleged by plaintiffs that the glyphosate-based herbicide products are defective and that Monsanto knew, or should have k
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.MarketBeat
- Journal Retracts 'Ghost Written' Monsanto Study Claiming Glyphosate Is Safe [zero hedge]zero hedge
- Study that said glyphosate herbicide is safe retracted 25 years after publication [Yahoo! Finance Canada]Yahoo! Finance Canada
- Bayer Starts Phase IIa Study for Treatment of Patients With Alport SyndromeBusiness Wire
- Taboo no more: Leaders gather to discuss women's health [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The